A Study to Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab 12-month Intensive Pharmacovigilance Protocol
- Status
- COMPLETED
- Phase
- N/A
Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Drug Interaction & Methadone & Buprenorphine
- Status
- COMPLETED
- Phase
- PHASE1
An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)
- Status
- COMPLETED
- Phase
- PHASE2
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
- Status
- COMPLETED
- Phase
- N/A
Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study
- Status
- COMPLETED
- Phase
- PHASE1
Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)
- Status
- UNKNOWN
- Phase
- N/A
Phase 1 Oral Solution and Crushed Tablet Relative Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.
- Status
- COMPLETED
- Phase
- PHASE3
Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant
- Status
- COMPLETED
- Phase
- PHASE3